77 results
Page 2 of 4
6-K
EX-99.1
cdzs8sjaimli
12 May 22
Current report (foreign)
8:30am
6-K
EX-99.1
3xi166 07p1sir
10 Jan 22
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
7:30am
6-K
EX-99.2
ebahm
10 Jan 22
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
7:30am
6-K
EX-99.2
pp4y62hoh8n0nt4
15 Nov 21
Current report (foreign)
7:36am
6-K
EX-99.1
3x6e4ivjeqllch
5 Nov 21
Current report (foreign)
7:30am
6-K
EX-99.1
aswsi5qttlgvkkf4jyb6
5 Aug 21
Current report (foreign)
8:23am
6-K
EX-99.1
azjdf1 orhh0qtwd
12 May 21
Current report (foreign)
4:30pm
6-K
EX-99.1
3zsgpa ob
1 Mar 21
Current report (foreign)
12:00am
424B5
e9nd4vhoeu
26 Feb 21
Prospectus supplement for primary offering
5:10pm
424B5
9yby2 4207y
24 Feb 21
Prospectus supplement for primary offering
5:16pm
6-K
dri5xudw0zy
24 Feb 21
Current report (foreign)
4:16pm
6-K
EX-99.2
8qknzse
11 Jan 21
InflaRx Provides Update on Vilobelimab (IFX-1) Development
7:30am
6-K
EX-99.1
1ffg hc8ojaweci33
29 Oct 20
Current report (foreign)
7:05am
S-8
EX-5.1
9nbakt9jepuft8d0
30 Jul 20
Registration of securities for employees
8:39am
S-8
EX-99.2
l1cg4glwk6lrw0oe3
30 Jul 20
Registration of securities for employees
8:39am